|
Market Cap (5-Jul) $37,640,252 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (19-Jun) 470,735 (0.11%) (418th) |
|
52w High $0.130 |
52w Low $0.082 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 7 December 2021, 9:08. The announcement is marked as price sensitive, and is 2 page(s) in length and 201.34kb in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 2.674% short sold according to ASIC data. It was ranked the 65th most shorted stock on the ASX. It remains ranked 418th as of the latest reported data (19 June 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| Starpharma signs DEP Research Agreement with US Biopharma Co | 7 December 2021, 9:08 |
| Change in Director's Interest Notice - J Fairley | 3 December 2021, 14:30 |
| Notification regarding unquoted securities - SPL | 3 December 2021, 14:26 |
| VIRALEZE distribution agreement and launch in Vietnam | 3 December 2021, 9:34 |
You must be logged in to post a reply.
Starpharma Holdings 